Physician profile
Alexus A Stephens
NPI 1861000564
$2,947.97
in general payments reported to CMS, 2019-2025
26 companies · $509 in 2025
The $509 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $440 · 2022: $822 · 2023: $717 · 2024: $460 · 2025: $509.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,655 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,654.86 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $350.16 | 2023-2024 | Speedicath |
| Teleflex LLC | $336.68 | 2021-2024 | |
| Myriad Genetic Laboratories, INC. | $255.75 | 2021-2024 | Prolaris |
| Axonics, INC. | $247.96 | 2022-2023 | Axonics, Bulkamid |
| Endo Pharmaceuticals INC. | $186.49 | 2021-2023 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $175.46 | 2022-2025 | Carvykti, Rybrevant, Erleada |
| Procept Biorobotics Corporation | $159.01 | 2022-2023 | Aquabeam Robotic System |
| Medtronic, INC. | $143.98 | 2022-2024 | Interstim |
| Astrazeneca Pharmaceuticals LP | $142.06 | 2023 | Lynparza |
| Astellas Pharma US INC | $137.97 | 2021-2022 | |
| Pfizer INC. | $118.60 | 2025 | |
| Smith+Nephew, INC. | $101.40 | 2025 | Grafix |
| Coopersurgical, INC. | $94.62 | 2021 | |
| Boston Scientific Corporation | $76.95 | 2021-2024 | Solyx Sis System |
| Calyxo, INC. | $68.39 | 2024-2025 | Cvac Aspiration System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Accord Healthcare, INC. | $61.82 | 2022 | |
| Sumitomo Pharma America, INC. | $56.65 | 2024-2025 | Gemtesa |
| Abbvie INC. | $43.01 | 2023-2024 | |
| Tersera Therapeutics LLC | $36.35 | 2025 | Zoladex |
| Myovant Sciences INC. | $35.33 | 2021 | |
| Progenics Pharmaceuticals, INC. | $26.50 | 2025 | |
| Merck Sharp & Dohme LLC | $24.32 | 2022 | |
| 180 Medical, INC. | $23.75 | 2023 | Speedicath |
| Urogen Pharma, INC. | $16.53 | 2024 | |
| Photocure INC | $16.30 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $11.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexus Stephens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.